Search Results for: Ct

May 15, 2025

Lymph node macrophages drive immune tolerance and resistance to cancer therapy by induction of the immune-regulatory cytokine IL-33.

Melanoma Literature

Publication date: May 12, 2025 Apoptotic cells are immunosuppressive, creating a barrier in cancer treatment. Thus, we investigated immune responses to dying tumor cells after therapy in the tumor draining ... Read more

May 15, 2025

Is One Year Enough? Extended Adjuvant Dabrafenib Plus Trametinib for Chinese Patients With Resected Stage III Melanoma.

Melanoma Literature

Publication date: May 14, 2025 Pathogenic BRAF mutations drive constitutive MAPK pathway activation in melanoma, and targeted therapies with dabrafenib plus trametinib have improved outcomes in the adjuvant setting. However, ... Read more

$Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases.$

May 15, 2025

Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases.

Melanoma Literature

Publication date: May 13, 2025 Radiation necrosis (RN) is a potential complication after stereotactic radiosurgery (SRS) for brain metastases. This study develops a recursive partitioning analysis (RPA) to identify patients ... Read more

May 15, 2025

A fermented Mistletoe (Viscum album L.) extract elicits markers characteristic for immunogenic cell death driven by endoplasmic reticulum stress in vitro.

Melanoma Literature

Publication date: May 14, 2025 Immune evasion is a characteristic hallmark of cancer. Immunotherapies aim to activate and support the body’s immune system to recognize and fight tumor cells. Induction ... Read more

May 15, 2025

Trends in kidney cancer: exploring the impact of sex and age on stage of disease, and prognosis during the past three decades in Denmark-a DaRenCa study.

Melanoma Literature

Publication date: May 14, 2025 Renal cell carcinoma (RCC) management has advanced due to increased imaging-based diagnoses and improved therapies for metastatic disease. This nationwide registry-based cohort study examines changes ... Read more

May 15, 2025May 15, 2025

Flow Cytometry Can Reliably Identify CTC in Melanoma

Melanoma News

Publication date: May 15, 2025 Circulating tumor cells (CTCs) are a reliable marker of disease progression in melanoma and can reliably be detected using flow cytometry, suggests a small study ... Read more

May 15, 2025

The Intersection of Genetics and Neuroimaging: A Systematic Review of Imaging Genetics in Neurological Disease for Personalized Treatment.

Parkinson's Disease Literature

Publication date: May 13, 2025 Imaging genetics is one of the important keys to precision medicine that leads to personalized treatment based on a patient’s genetics, phenotype, or psychosocial characteristics. ... Read more

May 15, 2025

Cu-bis(thioureido) Complex: A Potential Radiotracer for Detecting Oxidative Stress and Neuroinflammation in Neurodegenerative Diseases.

Parkinson's Disease Literature

Publication date: May 12, 2025 Neurodegenerative diseases, characterized by progressive neuronal degeneration and associated with neuroinflammation and oxidative stress, present significant challenges in diagnosis and treatment. This review explores the ... Read more

May 15, 2025

Gut microbiota regulation by Lactiplantibacillus plantarum SG5 enhances mitochondrial function in Parkinson’s disease mice via the GLP-1/PGC-1α pathway.

Parkinson's Disease Literature

Publication date: May 12, 2025 Motor dysfunction constitutes a prominent characteristic of Parkinson’s disease (PD), a neurodegenerative disorder associated with compromised mitochondrial activity, perturbed gut microbial composition, and neuronal loss. ... Read more

May 15, 2025

Predicting dementia in people with Parkinson’s disease.

Parkinson's Disease Literature

Publication date: May 13, 2025 Parkinson’s disease (PD) exhibits a variety of symptoms, with approximately 25% of patients experiencing mild cognitive impairment and 45% developing dementia within ten years of ... Read more